Agilent Technologies’ Custom-Designed CGH Microarray Used to Map Korean Genome

Agilent Technologies Inc. (NYSE: A) today announced that scientists using an Agilent custom-designed comparative genomic hybridization (CGH) array have sequenced the entire gene map of a Korean male. An international team led by researchers at Seoul National University published the results in Nature.

Source: Agilent